Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane R Parnes

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|February 20, 2019
Pharmacokinetics, Safety, and Tolerability of Tezepelumab (AMG 157) in Healthy and Atopic Dermatitis Adult SubjectsJane R Parnes, John T Sullivan, Li Chen, et al.
Journal of Asthma and Allergy|January 20, 2021
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b StudyJonathan Corren, Martin Karpefors, Åsa Hellqvist, et al.
Journal of Asthma and Allergy|February 11, 2021
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A <i>Post Hoc</i> Analysis of the Phase 2b PATHWAY StudyClaire Emson, Jonathan Corren, Kinga Sałapa, et al.
Gene|November 6, 2004
Woodchuck interleukin-6 gene: structure, characterization, and biologic activityDaniel H Li, Atsushi Kumanogoh, Thai M Cao, et al.
Journal of Asthma and Allergy|January 20, 2025
Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of ActionAndrew W Lindsley, Njira Lugogo, Kaitlin A G Reeh, et al.
Molecular Immunology|May 19, 2005
Mouse splenic B lymphocyte activation using different activation stimuli induces in vitro splicing of tumor necrosis factor-alpha nuclear pre-mRNAYi-Yang Yvonne Li, Yang Yang, Ming Bao, et al.
Journal of Asthma and Allergy|June 10, 2022
Targeting TSLP in AsthmaJane R Parnes, Nestor A Molfino, Gene Colice, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 17, 2021
Tezepelumab normalizes serum interleukin-5 and -13 levels in patients with severe, uncontrolled asthmaTuyet-Hang Pham, Claudia Chen, Gene Colice, et al.
European Journal of Immunology|April 9, 2005
Dual regulation of BCR-mediated growth inhibition signaling by CD72Takeshi Baba, Noemi Fusaki, Akitoshi Aoyama, et al.
Blood|December 15, 2005
Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cellsAukje W Zimmerman, Ben Joosten, Ruurd Torensma, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|February 20, 2019
Pharmacokinetics, Safety, and Tolerability of Tezepelumab (AMG 157) in Healthy and Atopic Dermatitis Adult SubjectsJane R Parnes, John T Sullivan, Li Chen, et al.
Journal of Asthma and Allergy|January 20, 2021
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b StudyJonathan Corren, Martin Karpefors, Åsa Hellqvist, et al.
Journal of Asthma and Allergy|February 11, 2021
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A <i>Post Hoc</i> Analysis of the Phase 2b PATHWAY StudyClaire Emson, Jonathan Corren, Kinga Sałapa, et al.
Gene|November 6, 2004
Woodchuck interleukin-6 gene: structure, characterization, and biologic activityDaniel H Li, Atsushi Kumanogoh, Thai M Cao, et al.
Journal of Asthma and Allergy|January 20, 2025
Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of ActionAndrew W Lindsley, Njira Lugogo, Kaitlin A G Reeh, et al.
Molecular Immunology|May 19, 2005
Mouse splenic B lymphocyte activation using different activation stimuli induces in vitro splicing of tumor necrosis factor-alpha nuclear pre-mRNAYi-Yang Yvonne Li, Yang Yang, Ming Bao, et al.
Journal of Asthma and Allergy|June 10, 2022
Targeting TSLP in AsthmaJane R Parnes, Nestor A Molfino, Gene Colice, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 17, 2021
Tezepelumab normalizes serum interleukin-5 and -13 levels in patients with severe, uncontrolled asthmaTuyet-Hang Pham, Claudia Chen, Gene Colice, et al.
European Journal of Immunology|April 9, 2005
Dual regulation of BCR-mediated growth inhibition signaling by CD72Takeshi Baba, Noemi Fusaki, Akitoshi Aoyama, et al.
Blood|December 15, 2005
Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cellsAukje W Zimmerman, Ben Joosten, Ruurd Torensma, et al.
Pageof 5